Skip to main content
letter
. 2018 Jan 15;19:8. doi: 10.1186/s12931-017-0712-9

Table 1.

Patients characteristics (n = 63)

Clinical profile
 Female/male [n (%)] 32 (50.2) / 31 (49.8)
 Age (years) 66.1 ± 1.7
 BMI (kg/m2) 26.0 (18.0–43.0)
NT-proBNP
 NT-proBNP at rest (pg/ml) 1414 (38–13,538)
 NT-proBNP at exercise (pg/ml) 1500 (42–14,365)
 NT-proBNP ratio 6.95 (0.09–60.60)
 ΔNT-proBNP (pg/ml) 77 (0–1160)
6-min walking test
 Distance (m) 300 (100–570)
 % of norm (%) 63.0 ± 3.2
 Breaks (n) 0 (0–4)
 Borg scale points (1–10) 4 (0–10)
Right heart catheterisation
 Mean PAP (mmHg) 39.0 ± 1.5
 Cardiac output (l/min) 4.10 (2.30–8.90)
 Cardiac index (l/min/m2) 2.35 ± 0.10
 PVR (Wood Units) 7.45 (3.04–14.20)
 Mean RAP (mmHg) 6.00 (1.00–20.00)
 SvO2 (%) 61.1 ± 1.04
Lung function
 DLCO (%) 52.6 ± 3.30
 PaO2 at rest (mmHg) 58.0 ± 1.70
 PaO2 at peak exercise (mmHg) 58.0 ± 2.27
Cardiopulmonary exercise testing
 Work capacity (watts) 45.0 (25–122)
 VO2 (ml/min) 941 ± 41.5
 VO2 (ml/min/kg) 12.7 ± 0.5
 AT (ml/min/kg) 9.43 ± 0.37
 O2 pulse at peak exercise (ml/min/beat) 8.46 ± 0.34
 Ve (L/min) 50.8 ± 2.23
 Ve/VO2 39.0 (25.0–77.0)
 Ve/VCO2 44.0 (28.0–87.0)
 AaDO2 (mmHg) 48.1 ± 2.2
 Vd/Vt (%) 36.7 ± 1.7
 Ve/VCO2 Slope 39.5 (14.3–107)

When not stated otherwise, data are presented as mean ± SEM or as median (range)